Direxion Shares ETF Trust (CURE)
Management Company · ARCX · Series S000027486 · View on SEC EDGAR ↗
- Net assets
- $138.3M
- Holdings
- 66
- As of
- April 30, 2026 stale
- Top 10 holdings weight
- 72.49%
- Effective number of positions
- 11.7
- Positions above 1%
- 25
On this page
- Fund flows Money flowing in and out of the fund each month, from N-PORT filings.
- Holdings Every position the fund currently holds, with weights.
- Sector breakdown How the fund's holdings split across market sectors.
- Institutional owners 13F institutions that report holding this ETF.
- Similar funds Other funds with overlapping holdings or comparable size.
Fund flows (SEC-reported)
- Last month (Apr 2026)
- +$13.0M
- Quarter ending Apr 2026
- +$1.8M
- Trailing 12 months
- -$16.2M
May 2025 – Apr 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 66 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| GOLDMAN FINANCIAL | — | $25.9M | 18.73 | 25,909,233 | STIV | US |
| DREYFUS GOVERNMENT CASH MANAGE | — | $16.4M | 11.86 | 16,397,579 | STIV | US |
| ELI LILLY & COMPANY | 532457108 | $14.8M | 10.68 | 15,801 | EC | US |
| JOHNSON & JOHNSON | 478160104 | $11.0M | 7.99 | 48,053 | EC | US |
| AbbVie Inc. | 00287Y109 | $7.4M | 5.39 | 35,243 | EC | US |
| UnitedHealth Group Inc. | 91324P102 | $6.7M | 4.84 | 18,062 | EC | US |
| MERCK & COMPANY INC | 58933Y105 | $5.4M | 3.91 | 49,491 | EC | US |
| GOLDMAN SACHS LIQ ES FD A | — | $5.3M | 3.82 | 5,280,551 | STIV | US |
| Amgen Inc. | 031162100 | $3.7M | 2.69 | 10,737 | EC | US |
| Thermo Fisher Scientific Inc | 883556102 | $3.6M | 2.59 | 7,491 | EC | US |
| Intuitive Surgical Inc. | 46120E602 | $3.2M | 2.34 | 7,081 | EC | US |
| Gilead Sciences Inc. | 375558103 | $3.2M | 2.34 | 24,739 | EC | US |
| Abbott Laboratories | 002824100 | $3.1M | 2.28 | 34,673 | EC | US |
| PFIZER INC | 717081103 | $3.0M | 2.19 | 113,370 | EC | US |
| BRISTOL-MYERS SQUIBB COMPANY | 110122108 | $2.5M | 1.78 | 40,606 | EC | US |
| Danaher Corporation | 235851102 | $2.2M | 1.62 | 12,545 | EC | US |
| VERTEX PHARMACEUTICALS INC | 92532F100 | $2.2M | 1.57 | 5,065 | EC | US |
| Stryker Corporation | 863667101 | $2.2M | 1.56 | 6,868 | EC | US |
| CVS Health Corp | 126650100 | $2.1M | 1.53 | 25,368 | EC | US |
| Medtronic PLC | G5960L103 | $2.1M | 1.50 | 25,563 | EC | US |
| Mckesson Corp. | 58155Q103 | $2.0M | 1.44 | 2,443 | EC | US |
| Boston Scientific Corporation | 101137107 | $1.7M | 1.23 | 29,571 | EC | US |
| ELEVANCE HEALTH INC | 036752103 | $1.7M | 1.20 | 4,402 | EC | US |
| CIGNA GROUP (THE) | 125523100 | $1.5M | 1.10 | 5,254 | EC | US |
| REGENERON PHARMACEUTICALS INC | 75886F107 | $1.4M | 1.03 | 2,010 | EC | US |
| HCA Healthcare Inc | 40412C101 | $1.4M | 0.98 | 3,122 | EC | US |
| CENCORA INC | 03073E105 | $1.2M | 0.86 | 3,879 | EC | US |
| ZOETIS INC | 98978V103 | $968K | 0.70 | 8,418 | EC | US |
| Edwards Lifesciences Corporation | 28176E108 | $966K | 0.70 | 11,571 | EC | US |
| Cardinal Health, Inc. | 14149Y108 | $905K | 0.65 | 4,692 | EC | US |
| IDEXX Laboratories Inc. | 45168D104 | $893K | 0.65 | 1,593 | EC | US |
| BECTON DICKINSON & COMPANY | 075887109 | $846K | 0.61 | 5,676 | EC | US |
| Agilent Technologies Inc. | 00846U101 | $652K | 0.47 | 5,640 | EC | US |
| ResMed Inc. | 761152107 | $621K | 0.45 | 2,905 | EC | US |
| Waters Corporation | 941848103 | $605K | 0.44 | 1,957 | EC | US |
| Humana Inc. | 444859102 | $568K | 0.41 | 2,404 | EC | US |
| Biogen Inc | 09062X103 | $554K | 0.40 | 2,927 | EC | US |
| GE HEALTHCARE TECHNOLOGIES INC | 36266G107 | $553K | 0.40 | 9,086 | EC | US |
| IQVIA Holdings Inc. | 46266C105 | $536K | 0.39 | 3,383 | EC | US |
| METTLER-TOLEDO INTERNATIONAL INC | 592688105 | $518K | 0.37 | 406 | EC | US |
| Centene Corp. | 15135B101 | $500K | 0.36 | 9,315 | EC | US |
| DexCom Inc | 252131107 | $457K | 0.33 | 7,675 | EC | US |
| WEST PHARMACEUTICAL SERVICES INC | 955306105 | $427K | 0.31 | 1,434 | EC | US |
| Quest Diagnostics Incorporated | 74834L100 | $426K | 0.31 | 2,194 | EC | US |
| Steris PLC | G8473T100 | $424K | 0.31 | 1,957 | EC | US |
| Labcorp Holdings Inc | 504922105 | $424K | 0.31 | 1,652 | EC | US |
| VIATRIS INC | 92556V106 | $343K | 0.25 | 22,967 | EC | US |
| Zimmer Biomet Holdings Inc | 98956P102 | $326K | 0.24 | 3,951 | EC | US |
| Moderna Inc | 60770K107 | $319K | 0.23 | 6,933 | EC | US |
| Incyte Corporation. | 45337C102 | $318K | 0.23 | 3,334 | EC | US |
Sector breakdown
Institutional owners (13F) 27 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | $6,337,605 | 16.05% | 56,500 | Call option | June 30, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6,259,086 | 15.85% | 55,800 | Put option | June 30, 2026 |
| GOLDMAN SACHS GROUP INC | $4,616,693 | 11.69% | 41,158 | Shares | June 30, 2026 |
| CITADEL ADVISORS LLC | $4,430,715 | 11.22% | 39,500 | Put option | June 30, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3,701,610 | 9.37% | 33,000 | Call option | June 30, 2026 |
| JANE STREET GROUP, LLC | $3,320,232 | 8.41% | 29,600 | Put option | June 30, 2026 |
| JANE STREET GROUP, LLC | $2,820,066 | 7.14% | 25,141 | Shares | June 30, 2026 |
| Bullseye Investment Management, LLC | $1,745,618 | 4.42% | 16,374 | Shares | Sept. 30, 2025 |
| Belvedere Trading LLC | $1,435,776 | 3.64% | 12,800 | Call option | June 30, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,090,180 | 2.76% | 9,719 | Shares | June 30, 2026 |
| JANE STREET GROUP, LLC | $886,143 | 2.24% | 7,900 | Call option | June 30, 2026 |
| SBI Securities Co., Ltd. | $559,392 | 1.42% | 4,987 | Shares | June 30, 2026 |
| Traynor Capital Management, Inc. | $531,353 | 1.35% | 4,737 | Shares | June 30, 2026 |
| Summit Financial, LLC | $460,448 | 1.17% | 4,105 | Shares | June 30, 2026 |
| Larson Financial Group LLC | $319,401 | 0.81% | 2,847 | Shares | June 30, 2026 |
| Onyx Bridge Wealth Group LLC | $279,640 | 0.71% | 2,493 | Shares | June 30, 2026 |
| StoneX Group Inc. | $227,620 | 0.58% | 2,316 | Shares | June 30, 2026 |
| Qube Research & Technologies Ltd | $135,950 | 0.34% | 1,212 | Shares | June 30, 2026 |
| SIMPLEX TRADING, LLC | $118,563 | 0.30% | 1,057 | Shares | June 30, 2026 |
| UBS Group AG | $95,345 | 0.24% | 850 | Shares | June 30, 2026 |
| Pinnacle Wealth Planning Services, Inc. | $48,682 | 0.12% | 434 | Shares | June 30, 2026 |
| Farther Finance Advisors, LLC | $37,016 | 0.09% | 330 | Shares | June 30, 2026 |
| OSAIC HOLDINGS, INC. | $21,841 | 0.06% | 194 | Shares | June 30, 2026 |
| CIBC Private Wealth Group LLC | $12,528 | 0.03% | 150 | Shares | Sept. 30, 2025 |
| ROYAL BANK OF CANADA | $4,000 | 0.01% | 35 | Shares | June 30, 2026 |
| MORGAN STANLEY | $141 | 0.00% | 1 | Shares | June 30, 2026 |
| WELLS FARGO & COMPANY/MN | $105 | 0.00% | 1 | Shares | June 30, 2026 |
Peer funds
More from this issuer
| Fund | AUM |
|---|---|
| SOXL Direxion Shares ETF Trust | $16.9B |
| SPXL Direxion Shares ETF Trust | $5.9B |
| TSLL Direxion Shares ETF Trust | $5.0B |
| TECL Direxion Shares ETF Trust | $4.7B |
| TMF Direxion Shares ETF Trust | $2.7B |
| FAS Direxion Shares ETF Trust | $2.0B |
| SOXS Direxion Shares ETF Trust | $1.9B |
| KORU Direxion Shares ETF Trust | $1.6B |
| TNA Direxion Shares ETF Trust | $1.5B |
| MUU Direxion Shares ETF Trust | $1.4B |
Similar by size
| Fund | AUM |
|---|---|
| RVNU DBX ETF Trust | $138.4M |
| FAB First Trust Exchange-Traded Alp… | $138.8M |
| IZRL ARK ETF Trust | $139.3M |
| GMOM Cambria ETF Trust | $140.3M |
| ONEZ Elevation Series Trust | $140.6M |
| PXJ Invesco Exchange-Traded Fund Tr… | $138.0M |
| AUGW AIM ETF Products Trust | $138.0M |
| HTUS Capitol Series Trust | $138.0M |
| LGDX Tidal Trust III | $137.9M |
| COLO Global X Funds | $137.8M |